The Legal 500

Twitter Logo Youtube Circle Icon LinkedIn Icon

Pearl Cohen Zedek Latzer Baratz

AZRIELI SARONA TOWER, 121 MENACHEM BEGIN ROAD, 53RD FLOOR, TEL AVIV, 6701203, ISRAEL
Tel:
Work +972-3-303-9000
Fax:
Fax +972-3-303-9001
Email:
Web:
www.pearlcohen.com
Boston, Haifa, London, New York, Tel Aviv

Israel

Capital markets
Capital markets - ranked: tier 3

Pearl Cohen Zedek Latzer Baratz

With on-the-ground teams in Tel Aviv and New York, Pearl Cohen Zedek Latzer Baratz is well positioned to assist dual-listed corporates with securities issues in Israel and the US. Known for its IP and hi-tech roots, the firm has particular expertise acting for growth companies in the life sciences and healthcare sectors. Department head Ilan Gerzi acted for BiondVax Pharmaceuticals in relation to a shelf prospectus offering on Nasdaq; Gerzi also assisted the client with the delisting of the company's shares from the TASE, making Nasdaq its primary securities market. Other key clients include Medipower (Overseas), Together Start Up Network and Kadimastem.

[back to top]

Commercial, corporate and M&A
Commercial, corporate and M&A - ranked: tier 4

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz has 'a comprehensive approach to doing business across multiple industries, and the team understands each one down to the very finest details'. Led jointly by Doron Latzer and Yael Baratz, the corporate group has complementary strengths in cross-border investment and M&A and high-value commercial and joint venture agreements. In a cross-border mandate, Yossi Weinstock advised Telit Communications on the $105m sale of its auto division to TUS International. Another key figure in the team is Ilan Gerzi, who advised Together Start Up Network on a high-value merger transaction in the medical cannabis sector. In the commercial space, Hili Rashkovan acted for Phinergy in relation to a strategic joint venture with a Chinese state-owned metal conglomerate.

[back to top]

Employment
Employment - ranked: tier 3

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz advises its corporate clients on a range of ongoing labour and employment matters, from HR policy advice to terminations, and also handles employment litigation. The employment group is led by Kalia Klein, who recently acted for manufacturer in relation to a collective agreement signed with the Histadrut, and also represented an infrastructure company in negotiations with the Histadrut regarding the integration of certain employees into the company. Klein has also handled employment litigation.

[back to top]

Healthcare and life sciences
Healthcare and life sciences - ranked: tier 2

Pearl Cohen Zedek Latzer Baratz

From IP, to licensing and distribution, finance and acquisitions, and clinical trials, Pearl Cohen Zedek Latzer Baratz services the full spectrum of commercial needs for domestic and international clients in the healthcare and life sciences sector. The department is headed by Yael Baratz and Mark Cohen, the latter of whom splits his time between the firm's New York and Tel Aviv offices. Of note, Cohen is advising OPKO Biologics on agreements relating to its phase-III clinical trials across 80 sites globally. Additionally, Cohen assisted Ayala Pharmaceuticals with the establishment of a worldwide license agreement with Bristol-Myers Squibb. The team headed by Marcella Eytan, also advises Chiasma Inc on clinical trial-related agreements and documents for its phase III clinical trials in 17 countries worldwide. Moreover, the firm, which is perhaps best known for its IP capabilities, has helped build patent portfolios for pharmaceutical companies including Sanofi and Sol-Gel Technologies.

[back to top]

Hi-tech and start-ups
Hi-tech and start-ups - ranked: tier 2

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz's tech sector strengths include both company- and investor-side work, which sees the firm involved in major cross-border commercial agreements, investment deals, fund formation, and M&A. Atir Jaffe is the firm's key contact for funds and investment work; he recently advised 2B Angels on a Series D investment in Yotpo in a financing round totalling $51m. On the company side, Guy Lachmann acted for Rookout in a Series A financing round led by TLV Partners VC, and has also handled various financing transactions for cyber companies Convexum and Unbotify. Also of note, Hili Rashkovan assisted Phinergy with a $128m joint venture with Yunnan Aluminum, and also advised the client on an additional $73m licensing deal with a separate Chinese company. Other major investor clients include AP Capital Partners Fund, Amoon Ventures, while company side clients include fintech company Nayax and Algaennovation, which develops technology for sustainable indoor microalgae cultivation.

[back to top]

Intellectual property: commercial/transactions
Intellectual property: commercial/transactions - ranked: tier 2

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz is an established name in Israel's IP market, and with strong practices in hi-tech and healthcare, the firm is regularly involved in domestic and multinational licensing transactions, clinical trials, and R&D agreements. In a stand-out matter, Zeev Pearl and Hili Rashkovan advised Phinergy on a $73m out-licensing agreement with China's Yunnan Aluminium. Mark Cohen, who splits his time between the firm's Tel Aviv and New York offices, is acting for Ayala Pharmaceuticals in relation to the establishment of an exclusive worldwide licensing arrangement with Bristol-Myers Squibb. In the domestic market, Yael Baratz and Marcella Eytan advised an R&D company on a collaborative research, option and licensing agreement with a medtech company involving technology for the detection of the cell origin of tissue-specific DNA. Baratz is also engaged by the tech-transfer arm of Hadassah Medical Organisation. Also recommended is Haim Ravia, who specialises in cyber, data protection and internet law, and has advised ACUM on multiple licensing deals with international music services.

[back to top]

Intellectual property: disputes
Intellectual property: disputes - ranked: tier 2

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz has considerable strengths in patent litigation in the life sciences and hi-tech sectors, and has also been involved in complex trade mark and IP ownership disputes. In the patent space, managing partner Zeev Pearl represented a multinational healthcare company in patent proceedings before the registrar concerning the applicability of Israeli law to biologics as opposed to chemical drugs. Pearl has also handled opposition proceedings for client such as Dimerix Bioscience PTY and CSL Behring. Additionally, Yossi Markovich is representing a prominent Israeli R&D company in a patent ownership dispute with the Kimron Veterinary Institute involving questions of statute of limitation. Trade mark disputes include Markovich and Dor Cohen Zedek acting for a sports retailer in a long-running opposition against Brooks Sports; following a successful outcome for the client, Brooks Sports has appealed to the District Court.

[back to top]

Intellectual property: filing/prosecution
Intellectual property: filing and prosecution: patents - ranked: tier 1

Pearl Cohen Zedek Latzer Baratz

Intellectual property: filing and prosecution: trade marks and copyrights - ranked: tier 1

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz is 'experienced in every facet of the IP market' and provides 'intimate partner involvement in each and every filing procedure'. One of the firm's major attractions is its global network. With offices and key partners in Israel, the US and the UK, the team is able to manage the contentious and non-contentious aspects of major international IP portfolios. Managing partner Zeev Pearl handles worldwide patent applications for Sanofi and also handles Israeli patent applications for another prominent international pharmaceuticals company. Life sciences practice head Mark Cohen, who splits his time between New York and Tel Aviv, has been involved in worldwide patent applications for OPKO Health and Sol-Gel Technologies. The trade marks group is headed by Dor Cohen-Zedek, who advises a number of high-end fashion brands on trade mark strategy and prosecution. Moreover, the team handles design, trade mark and patent portfolios for clients such as Elbit Systems, Sodastream Industries, Aspect Imaging, and Yeda Research and Development Company.

[back to top]

Investment and venture capital funds
Investment and venture capital funds - ranked: tier 3

Pearl Cohen Zedek Latzer Baratz

Pearl Cohen Zedek Latzer Baratz's strong hi-tech practice has led to strong relationships with active venture capital firms; however, its expertise extends far beyond portfolio investment and the team advises various investors on the formation of venture capital, private equity and other types of funds. A key figure is hi-tech and venture capital specialist Atir Jaffe, who advised Keshet International Broadcasting on the formation of a $55m venture capital fund, and also assisted with the formation of the new Israeli impact fund, COPIA Agro & Food Technologies Fund. In the private equity space, the team handled the formation of the AP Partners Fund, which reached over $82m in its initial closing. Another important feature is the firm's global network, which includes US tax lawyer Oz Halabi, and uniquely positions the funds department to handle cross-border mandates.

[back to top]

Tax
Tax - ranked: tier 4

Pearl Cohen Zedek Latzer Baratz

The team at Pearl Cohen Zedek Latzer Baratz has 'a unique understanding of the intersection of domestic and international tax matters' and the firm has the global presence to field real experts in US, European and Israeli tax law. Henriette Fuchs chairs the Israel tax team and provides comprehensive tax advice to clients such as BIG Shopping Centers and Sierra Hamilton. Fuchs is also co-representing a client in tax litigation questioning the relevant legislation for the taxation of the client's activities beyond Israel's territorial waters. Based in the firm's New York office, Oz Halabi chair's the US tax team and regularly works alongside the Tel Aviv hi-tech practice in relation to the taxation of venture capital funds and cross-border investors.

[back to top]


Further information on Pearl Cohen Zedek Latzer Baratz

Please choose from this list to view details of what we say about Pearl Cohen Zedek Latzer Baratz in other jurisdictions.

Israel

Offices in Haifa and Tel Aviv

Legal Developments in Israel

Legal Developments and updates from the leading lawyers in each jurisdiction. To contribute, send an email request to
  • INVESTMENT OPPORTUNITIES FOR HNWIs IN ISRAEL‚ÄôS HI-TECH ECOSYSTEM

    Accredited investor funding platforms for innovative tech scale-ups offer more choice and without having to commit a large chunk of capital upfront, the risk is diluted.
  • Perhaps the QuadragaCX Story Will Have a Happy Ending

    While there are the aficionados who will say that cryptocurrencies will free us of the chains of the global financial institutions, on the occasions when the world of cryptocurrencies intersects with the world in which most of us live, the news is generally bleak. While you may not know one side of a Bitcoin from the other, you probably know that its value has crashed over the last 13 months, you may even have heard about some of some of the larger cryptohacks (that is computer heists through which digital currencies belonging to investors are stolen from crypto trading exchanges). And over the last week or so, you may have read on mainstream news sites about the death of Gerald Cotton the CEO of Canada‚Äôs largest cryptoexchange QuadragaCX. The death of the CEO of a company that few had previously heard of, was news of course, because in his passing he had taken the passwords to the accounts of his customers with him. The result of this being that about $140 million of their money was stuck somewhere between this world and the celestial ether in which Mr. Cotton now resides. Of course, it wasn‚Äôt quite told like that. We were fed terms such as ‚Äúprivate keys,‚ÄĚ lack of ‚Äúmulti-signature protection,‚ÄĚ ‚Äúcold storage wallets‚ÄĚ and more readily understandable ‚Äď ‚Äúcryptofraud‚ÄĚ. Again!
  • Israel Chapter in The Virtual Currency Regulation Review

    Earlier this year, the Israel Tax Authority (ITA) issued two circulars, one on the taxation of digital tokens and the second addressing the taxation of utility tokens in initial coin offerings (ICOs). Additionally, in March, the Israel Securities Authority (ISA) released a detailed interim report by the Committee for the Regulation of Public Offerings of Decentralized Cryptocurrency Coins (Report) (with a follow-up report due to come out around October 2018). Moreover, it is expected that before the end of 2018, legislation will come into force that for the first time will see Israeli primary legislation define virtual currencies as financial assets and mandate licensing for related services, as is later discussed in detail.
  • Spring is coming for real estate registration in Israel

    Israel may be the ‚ÄúStart-up Nation‚ÄĚ and a world-renowned center of technological innovation, yet for many years the procedures and conduct of the Israeli Land Registry have been trapped in the past.
  • PLATFORMS FOR HIGH NET WORTH INVESTORS IN ISRAELI HIGH-TECH

    Israeli hi-tech and its sources of funding have grown and diversified tremendously since the bubble burst in 2001 and over the last decade since the height of the financial crisis in 2007-2008.
  • NONDISCRIMINATION IN 5G STANDARDS

    Nondiscrimination has been the neglected stepchild of the FRAND commitment. Patent owners participating in standards organizations typically commit to license their technology on ‚Äúfair, reasonable, and nondiscriminatory (‚ÄúFRAND‚ÄĚ) terms.‚ÄĚ
  • Crash Course on Non-Disclosure Agreements

    Non-disclosure agreements are a crucial, but often overlooked, tool in allowing startup companies to grow, build strategic partnerships and explore new business relationships necessary to develop their product or bring it to market. These agreements are often short (sometimes only a page or two) and lead many founders to forego legal advice to get past this "formality" and begin working with the other party to the NDA. Yet, NDAs are important agreements with potentially far-reaching implications for the protection of a company's confidential information and intellectual property, and mishandling of NDAs can come back to haunt a startup years later.
  • Advocates Eli Greenbaum and Ezra Gross of Yigal Arnon & Co. in The Lawyer Special Report editorial

    An interview-style piece in The Lawyer, Law in Israel: moving beyond tech, quoting Eli Greenbaum and Ezra Gross:
  • Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain

    Publication of Adv. Adrian Daniel's Commentary in Private Banker International on GDPR & Blockchain.
  • Article in MEA Markets on GDPR & Israeli Law

    GDPR & ISRAELI PRIVACY LAW - KEY DIFFERENCES Yoheved Novogroder-Shoshan & Miriam Friedmann of Yigal Arnon & Co. outline the key differences between GDPR & Israeli Privacy Law.  mea_markets_-_gdpr__israeli_law_-_key_differences_14.05.2018